M1 Kliniken Aktie
WKN DE: A0STSQ / ISIN: DE000A0STSQ8
16.10.2025 18:39:23
|
EQS-Adhoc: M1 Kliniken AG: M1 Kliniken AG: HAEMATO AG sells its 100% subsidiary HAEMATO Pharm GmbH to PHOENIX group
EQS-Ad-hoc: M1 Kliniken AG / Key word(s): Disposal/Investment Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
M1 Kliniken AG announces that its 85% subsidiary, HAEMATO AG, today signed an agreement for the sale of its wholly owned subsidiary HAEMATO Pharm GmbH to the PHOENIX group, one of Europe’s leading healthcare providers headquartered in Mannheim. The completion of the transaction remains subject to the customary antitrust approvals. The parties have agreed not to disclose the financial details of the transaction. With this transaction, M1 Kliniken AG is consistently pursuing its strategic course to position itself as a globally leading, vertically integrated pure-play provider in the field of medical aesthetics. Contact: Attila Strauss, Management Board Corporate Communications E-Mail: ir@m1-kliniken.de End of Inside Information
16-Oct-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | M1 Kliniken AG |
Grünauer Straße 5 | |
12557 Berlin | |
Germany | |
Phone: | +49 (0)30 347 47 44 14 |
Fax: | +49 (0)30 347 47 44 17 |
E-mail: | ir@m1-kliniken.de |
Internet: | https://www.m1-kliniken.de |
ISIN: | DE000A0STSQ8 |
WKN: | A0STSQ |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2214474 |
End of Announcement | EQS News Service |
|
2214474 16-Oct-2025 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu M1 Kliniken AGmehr Nachrichten
Analysen zu M1 Kliniken AGmehr Analysen
Aktien in diesem Artikel
M1 Kliniken AG | 15,52 | 10,86% |
|